All Articles on COVID
COVID-19 vaccine generates immune response in older adultsThe investigational mRNA vaccine is also well tolerated, according to trial led by Kaiser Permanente Washington researcher and others.
Vaccine hesitancy in the time of COVID-19Can lessons from Immunity Community help build acceptance of COVID-19 vaccines? Clarissa Hsu, PhD, thinks so.
Finding evidence to drive COVID-era decisionsHow Paula Blasi brings research findings to light to support Kaiser Permanente’s rapid response to COVID-19
New Lancet report offers hope for preventing dementiaDr. Eric B. Larson, a report contributor, answers questions about reducing risks, disparities, and threats from COVID-19.
COVID-19 vaccine well tolerated, generates immune responseNational Institute of Allergy and Infectious Diseases-sponsored phase 1 trial tested mRNA vaccine.
5 questions with an influenza and COVID-19 epidemiologistDr. Mike Jackson has long studied the spread of flu and effectiveness of vaccination at Kaiser Permanente Washington. And now… of COVID-19 too.
How seniors can build resilience during pandemicOlder people must guard against social isolation, as well as COVID-19, to stay well and thrive, writes Dr. Eric B. Larson.
- ← Previous
- 1
- 2 (current)
- 3
- 4
- Next →
